- Home
- NL vs TARA Comparison
NL vs TARA Comparison
Compare NL & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NL | TARA |
|---|---|---|
| Founded | 1891 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 296.8M | 269.8M |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NL | TARA |
|---|---|---|
| Price | $6.01 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 106.0K | ★ 719.7K |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 10.22% | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $158,285,000.00 | $2,948,000.00 |
| Revenue This Year | $9.32 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $66.67 | ★ N/A |
| Revenue Growth | ★ 8.46 | N/A |
| 52 Week Low | $5.04 | $2.77 |
| 52 Week High | $8.60 | $7.82 |
Technical Indicators
Market Signals| Indicator | NL | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 32.74 |
| Support Level | $5.55 | $3.03 |
| Resistance Level | $6.32 | $5.53 |
| Average True Range (ATR) | 0.58 | 0.26 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 12.20 | 9.61 |
Price Performance
Historical ComparisonAbout NL NL Industries Inc.
NLI Holdings Inc, formerly known as NL Industries Inc, is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.